NEXEL will be participating in the 2025 Stanford Drug Discovery Symposium, held in Stanford University, USA.

 

For those attending this event, we look forward to meeting you at the venue! We also welcome you to visit us during poster sessions to learn more about our human iPSC-derived products, Cardiac Safety Evaluation Service, and human iPSC CDMO Services.

 

Stanford Drug Discovery Symposium, starting from its first event held in 2016, has served as a cornerstone to bring together the drug discovery community for networking and collaboration.

 

The symposium brings together members across multiple disciplines - research, pharmaceutical, investment, academia, regulatory, and many otheres - to share ideas and innovations.

 

The event will take places across two days, with multiple symposium sessions and poster sessions to present new ideas and results that will spark the next big steps in drug discovery.

 

For those who are interested in processes that are carried out in drug discovery, this event is a must-attend.